Tuesday, March 31, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

A conversation with Dr. Terri Lewis, thought leader for opioid policy reform

There are many prominent researchers working behind the scenes to rectify erroneous opioid policies at the state and federal level. Among these silent researchers, Dr. Terri Lewis’s work rings the loudest.

She has redefined the very meaning of data in the opioid epidemic, conducting one of the largest behavioral surveys on opioid use and the experience of chronic pain.

Through her research, we now know of inherent biases within the data used in opioid risk stratification, and the implications of these biases on the lives of chronic pain patients across the country.

It is because of researchers like Dr. Terri Lewis that we understand the value of prescription opioids through the voices of people with lived experience.

To glean preliminary results from her ongoing survey, please select the link below:

https://drive.google.com/file/d/1lOjfEJZz8ZbebSE4O-u3rM8Ka4RD8fZI/view?usp=sharing

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply

Your email address will not be published. Required fields are marked *

Videos

Policy Shift in Peptide Regulation

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

Semaglutide has moved beyond its original indication and now sits at the center of a widening set of clinical questions: cardiovascular risk, kidney disease progression, and even neurodegeneration. The question is no longer whether the drug lowers glucose or reduces weight—it does—but how far those effects extend across systems, and whether evidence from one population can be translated into another without distortion. Large, well-powered trials have produced consistent signals, yet those signals are now being applied in contexts that were...

Read more

Join Our Newsletter!